Family Medicine Preparedness for Hantavirus Infection: A Comprehensive Review of Early Recognition, Prevention, Outpatient Triage, and Referral Pathways

Background: Hantaviruses are rodent-borne zoonotic pathogens responsible for two major severe human syndromes: hantavirus pulmonary syndrome (HPS, also termed hantavirus cardiopulmonary syndrome, HCPS) in the Americas, and haemorrhagic fever with renal syndrome (HFRS) across Europe and Asia. Case-fatality reaches as high as 50% in severe New World HPS and up to 15% in severe Old World HFRS (1,2). The May 2026 multi-country Andes virus cluster aboard the MV Hondius cruise ship reawakened clinical interest in this group of viruses and underscored the pivotal frontline role of family physicians in early recognition and triage (3,4).
Objective: To synthesize the contemporary evidence on hantavirus epidemiology, clinical recognition, outpatient triage, prevention, and referral pathways with a practical orientation toward family medicine practice.
Methods: A narrative review of peer-reviewed literature retrieved from PubMed/MEDLINE and Scopus, supplemented by official CDC and WHO documents and current national clinical guidelines, published up to May 2026, was undertaken. Studies addressing virology, epidemiology, primary-care recognition, diagnostics, treatment escalation, and prevention were prioritized.
Results: The hantavirus prodrome is clinically indistinguishable from influenza-like illness, yet the classical tetrad on a basic peripheral blood smear — thrombocytopenia, left-shifted leukocytosis, circulating immunoblasts, and hemoconcentration — remains a powerful early discriminator that can be obtained in most outpatient settings (5,6). Clinical deterioration during the cardiopulmonary phase typically unfolds within 24 to 48 hours and demands immediate intensive-care referral; early venoarterial extracorporeal membrane oxygenation (VA-ECMO) at experienced centers has been associated with survival approaching 80% in otherwise refractory cases (5,7). No licensed antiviral or vaccine is yet available, leaving meticulous supportive care, conservative fluid strategy, and infection prevention as the cornerstones of management (1,2).
Conclusion: Family physicians must maintain a high index of suspicion for hantavirus disease in patients presenting with a febrile prodrome together with a rodent or relevant travel exposure history, perform rapid bedside risk stratification, expedite ICU referral when red-flag features appear, and reinforce community-level rodent control and safe cleaning practices. Their early decisions can shape outcomes more decisively than any downstream intervention.